Information  X 
Enter a valid email address

Company Name matching 'JP Morgan Sec LLC'

Date
Time Source
Company
Announcement
04 May 2020 11:46 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
01 May 2020 12:23 pm RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) Amendment
  12:22 pm RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3
  11:49 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
  11:48 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
30 Apr 2020 11:47 am RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3
  11:46 am RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3 Amendment
  11:42 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
  11:40 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
  11:38 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) Amendment
29 Apr 2020 12:21 pm RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3 Amendment
  12:18 pm RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3
  11:30 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) Amendment
  11:30 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
  11:29 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
28 Apr 2020 11:38 am RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3
  11:37 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
  11:37 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
27 Apr 2020 11:21 am RNS   JP Morgan Sec LLC Willis Towers Watson plc - 8.3
  11:20 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
  11:20 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) Amendment
  11:19 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
24 Apr 2020 12:20 pm RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3
  10:51 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) Amendment
  10:51 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
  10:49 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
23 Apr 2020 2:27 pm RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3 Amendment
  2:26 pm RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3
  11:55 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) Amendment
  11:52 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
  11:51 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
22 Apr 2020 11:50 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) Amendment
  11:49 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
  11:48 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
  11:46 am RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3
21 Apr 2020 3:45 pm RNS   JP Morgan Sec LLC Willis Towers Watson plc 8.3 - Replacement
  11:40 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
  11:39 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
20 Apr 2020 11:56 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
  11:53 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b) Amendment
  11:53 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) Amendment
  11:52 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
17 Apr 2020 5:11 pm RNS   JP Morgan Sec LLC Allergan plc 38.5(b) amendment
  11:48 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) amendment
  11:47 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
  11:47 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
16 Apr 2020 11:45 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
  11:44 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
15 Apr 2020 5:41 pm RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) amendment
  11:36 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
  11:34 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
14 Apr 2020 11:54 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b) amendment
  11:53 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) amendment
  11:52 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
  11:51 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
  7:00 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) amendment
  7:00 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b) amendment
  7:00 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b)
  7:00 am RNS   JP Morgan Sec LLC Allergan plc 38.5(b)
09 Apr 2020 11:54 am RNS   JP Morgan Sec LLC AbbVie Inc. 38.5(b) amendment


Company Announcements Archive »

 
Headlines
Top categories

03-Jul-2020 04:50 PM

Broker Forecast - Barclays Capital issues a broker note on Gamma Communications Plc

Barclays Capital today reaffirms its overweight investment rating on Gamma Communications Plc (LON:GAMA) and raised its price target to 1600p (from 15 ...

Company finder
Forthcoming announcements

a d v e r t i s e m e n t